These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29985757)

  • 1. Selling stem cell 'treatments' as research: prospective customer perspectives from crowdfunding campaigns.
    Snyder J; Turner L
    Regen Med; 2018 Jun; 13(4):375-384. PubMed ID: 29985757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.
    Turner L
    Perspect Biol Med; 2018; 61(1):7-24. PubMed ID: 29805145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crowdfunding, stem cell interventions and autism spectrum disorder: comparing campaigns related to an international "stem cell clinic" and US academic medical center.
    Snyder J; Turner L
    Cytotherapy; 2021 Mar; 23(3):198-202. PubMed ID: 33082092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the Regulation of Autologous Stem Cell Interventions in the United States.
    Sipp D
    Perspect Biol Med; 2018; 61(1):25-41. PubMed ID: 29805146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The politics of evidence in online illness narratives: An analysis of crowdfunding for purported stem cell treatments.
    Tanner C; Munsie M; Sipp D; Turner L; Wheatland C
    Health (London); 2019 Jul; 23(4):436-457. PubMed ID: 30782021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US stem cell clinics, patient safety, and the FDA.
    Turner L
    Trends Mol Med; 2015 May; 21(5):271-3. PubMed ID: 25945404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions.
    Turner L
    Cell Stem Cell; 2021 Nov; 28(11):1891-1895. PubMed ID: 34739831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions.
    Turner LG
    Regen Med; 2015 May; 10(4):397-402. PubMed ID: 26022761
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid change of a cohort of 570 unproven stem cell clinics in the USA over 3 years.
    Knoepfler PS
    Regen Med; 2019 Aug; 14(8):735-740. PubMed ID: 31456478
    [No Abstract]   [Full Text] [Related]  

  • 10. Media portrayal of illness-related medical crowdfunding: A content analysis of newspaper articles in the United States and Canada.
    Murdoch B; Marcon AR; Downie D; Caulfield T
    PLoS One; 2019; 14(4):e0215805. PubMed ID: 31013310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crowdfunding for stem cell-based interventions to treat neurologic diseases and injuries.
    Snyder J; Turner L
    Neurology; 2019 Aug; 93(6):252-258. PubMed ID: 31227615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-to-consumer marketing of stem cell interventions by Canadian businesses.
    Turner L
    Regen Med; 2018 Sep; 13(6):643-658. PubMed ID: 30255734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era.
    Turner L; Wang JC; Martinez JR; Najjar S; Rajapaksha Arachchilage T; Sahrai V
    Cytotherapy; 2024 Apr; 26(4):393-403. PubMed ID: 38340106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning the Tide on Unproven Cell-Based Interventions.
    Ikonomou L; Weiss DJ
    Chest; 2020 Apr; 157(4):774-775. PubMed ID: 32252930
    [No Abstract]   [Full Text] [Related]  

  • 15. From the margins to mainstream: How providers of autologous 'stem cell treatments' legitimise their practice in Australia.
    MacGregor C; Petersen A; Munsie M
    Health (London); 2021 Jan; 25(1):51-68. PubMed ID: 31081381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The direct-to-consumer market for stem cell-based interventions in Australia: exploring the experiences of patients.
    Waldby C; Hendl T; Kerridge I; Lipworth W; Lysaght T; Munsie M; Stewart C
    Regen Med; 2020 Jan; 15(1):1238-1249. PubMed ID: 32009513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Texas H.B. 810: Increased Access to Stem Cell Interventions or an Increase in Unproven Treatments?
    Matthews K; Kunisetty B; Sprung K
    Stem Cells Dev; 2018 Nov; 27(21):1463-1465. PubMed ID: 30122128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA's claims over stem cells upheld.
    Cyranoski D
    Nature; 2012 Aug; 488(7409):14. PubMed ID: 22859178
    [No Abstract]   [Full Text] [Related]  

  • 19. What Medical Crowdfunding Campaigns Can Tell Us About Local Health System Gaps and Deficiencies: Exploratory Analysis of British Columbia, Canada.
    Snyder J; Zenone M; Crooks V; Schuurman N
    J Med Internet Res; 2020 May; 22(5):e16982. PubMed ID: 32348269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marketing of unproven stem cell-based interventions: A call to action.
    Sipp D; Caulfield T; Kaye J; Barfoot J; Blackburn C; Chan S; De Luca M; Kent A; McCabe C; Munsie M; Sleeboom-Faulkner M; Sugarman J; van Zimmeren E; Zarzeczny A; Rasko JEJ
    Sci Transl Med; 2017 Jul; 9(397):. PubMed ID: 28679655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.